Heme arginate
Heme arginate is a pharmaceutical drug with 7 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
2
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Heme Arginate in Cardiac Surgery Patients
Effects of Heme Arginate in Healthy Male Subjects
Does Heme Oxygenase-1 Induction Ameliorate Cardiac Injury After Myocardial Infarction?
Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria
Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias
Clinical Trials (7)
Heme Arginate in Cardiac Surgery Patients
Effects of Heme Arginate in Healthy Male Subjects
Does Heme Oxygenase-1 Induction Ameliorate Cardiac Injury After Myocardial Infarction?
Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria
Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias
Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of Porphyria
Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7